Navigation Links
Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77
Date:1/24/2012

>

Business Segment Highlights for 2011"In the Global Generics business, U.S. growth was driven by continued solid performance of our base business, complemented by the addition of generic versions of Concerta®, Lipitor®, Kadian®, Seasonique® and LoSeasonique®.  We also continued to grow the international segment, reporting the highest growth rate of prescriptions in Canada; our UK business benefited from the successful launch of generic Nexium® under a license from AstraZeneca, and we saw growth in hospital sales in France," Bisaro told investors.  

"Our Global Brands business continued to benefit from the growth of our Rapaflo®, Gelnique® Crinone® and Androderm®  franchises, and we expanded the portfolio with the launch of Generess® Fe oral contraceptive and the Androderm® 2/4 mg strengths.  

In light of the reduced number of new product launches by third-parties, our Anda Distribution business performed as expected.   While we don't account for its contribution in divisional results, Anda provided strong execution support to Watson by playing a significant part in the successful launch of both generic Lipitor® and generic Concerta®.  

Finally, the strength of our global supply chain enabled us to capitalize on market opportunities resulting from challenges faced by competitors in the generic space."

Business Development AccomplishmentsThe Company noted that business development activities, funded by its strong balance sheet, resulted in the strategic acquisition of Specifar in May.  The company expanded its Global Brands business with the licensing of Antares' oxybutynin gel product, which will be launched in the U.S. and Canada in the first half of 2012. Additionally, the company announced its collaboration with Amgen for the development and commercialization of a portfolio of monoclonal antibody oncology products in late 2
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Watson Acquires Ascent Pharmahealth for AU$375 Million
2. Watson to Present at the 30th Annual J.P. Morgan Healthcare Conference
3. Watson to Present at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
4. Watson Launches Generic LoSEASONIQUE(R)
5. Watson Launches Generic LIPITOR®
6. Watson to Present at the 2011 Piper Jaffray Health Care Conference
7. Watson Wins Kentucky Drug Pricing Litigation
8. Watson Confirms Exelon(R) Patent Challenge
9. Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA
10. Watson Third Quarter 2011 Net Revenue Climbs 23% to $1.1 Billion; Non-GAAP Diluted EPS of $1.09; GAAP Diluted EPS of $0.54
11. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... KONG, Nov. 28, 2014 HK$,000Six months endedChange %  30 September ... Cord Blood Storage Service Income , 384,242 , ... , 61,878 , 41,377 , 49.5 ... 2,249 , 6.4 Medical Devices and Accessories Sales ... Chinese Herbal Medicines Sales , 2,917 , 9,219 ...
(Date:11/26/2014)...  Thoratec Corporation (NASDAQ: THOR ), a ... save, support and restore failing hearts, said today it ... On Tuesday, December 2, the company will participate ... Conference.  D. Keith Grossman , President and Chief ... beginning at 11:30 a.m., Eastern Standard Time (8:30 a.m., ...
(Date:11/26/2014)... -- Cohen, Placitella & Roth, PC is investigating potential ... Pharmaceutical Corporation ("Nymox" or "Company") (NASDAQ: ... 2011 through November 2, 2014 ("Class Period").  The ... officers and directors publically disseminated materially false and/or ... 20(a) of the Securities Exchange Act of 1934 ...
Breaking Medicine Technology:Golden Meditech Announces 2014 / 2015 Interim Results 2Golden Meditech Announces 2014 / 2015 Interim Results 3Golden Meditech Announces 2014 / 2015 Interim Results 4Golden Meditech Announces 2014 / 2015 Interim Results 5Golden Meditech Announces 2014 / 2015 Interim Results 6Golden Meditech Announces 2014 / 2015 Interim Results 7Golden Meditech Announces 2014 / 2015 Interim Results 8Thoratec Announces Presentations At Investor Conferences For December 2014 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3
... COLUMBIA, Md., Nov. 11, 2010 Celsion Corporation ... drug development company, today announced that the Committee ... Medicines Agency (EMA) has issued a positive opinion ... ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin, ...
... Arbor Pharmaceuticals, a specialty pharmaceutical company based in Atlanta, ... financing.  This financing included a $17.5 million investment in ... Signet Healthcare Partners, LLC.  The remainder of the financing ... by several of the investing parties.  Also participating in ...
Cached Medicine Technology:Celsion Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox® to Treat Primary Liver Cancer 2Celsion Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox® to Treat Primary Liver Cancer 3Celsion Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox® to Treat Primary Liver Cancer 4Arbor Pharmaceuticals Completes $34.8 Million Financing 2Arbor Pharmaceuticals Completes $34.8 Million Financing 3
(Date:11/28/2014)... 2014 Mirena lawsuits ( http://www.mirenalawsuit2014.com/ ... New Jersey’s Bergen County Superior Court, where the ... there is quickly approaching 1,300, Bernstein Liebhard LLP ... shows 1,293 lawsuits now pending in the consolidated ... complications resulting from spontaneous migration of the birth ...
(Date:11/28/2014)... Walder, one of South Florida’s top cosmetic dermatologists , ... that is designed to help her patients reduce unwanted fat ... has been praised by patients as being permanent, painless, and ... types of external fat reduction. , “If you can pinch ... According to Dr. Walder, Ultrashape works by targeting subcutaneous fat, ...
(Date:11/28/2014)... Texas (PRWEB) November 28, 2014 Dr. Paul Vitenas, ... will hold a Glitter & Glow Holiday Event for those in ... treatments offered at his practice. Glitter & Glow will take place ... Dr. Vitenas’ new location in the heart of Houston at 4208 ... of holidays and hope that you will come and celebrate the ...
(Date:11/28/2014)... 28, 2014 Secura Consultants, based ... insurance marketing organizations in the country focused on ... protection marketplace. Secura Consultants is proud to offer ... Financial Group, a leading global financial company. , ... With the ownership interest comes the need for ...
(Date:11/28/2014)... Celebration can quickly turn to tragedy if popular turkey ... Over the last decade, more than 141 serious fires ... turkey fryers, according to the U.S. Consumer Product Safety ... who tried to deep fry the turkey indoors, which ... Arthur Sanford, a burn surgeon at Loyola University Health ...
Breaking Medicine News(10 mins):Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 2Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 3Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3Health News:Secura Consultants Offers Complimentary Buy-Sell Agreement Reviews 2Health News:Turkey Fryer Mishaps Can Cause Serious Burns 2
... MONDAY, May 23 (HealthDay News) -- Women who gained 18 or ... three times more likely to develop gestational diabetes during their second ... the study, published in the May 23 online issue of ... to shed six or more pounds between babies cut their risk ...
... primary care specialty of internal medicine has identified common clinical ... care and better use of finite clinical resources. ... activities appears online in the Archives of Internal Medicine ... list of best practices via consensus from actual practitioners, said ...
... 23 (HealthDay News) -- Researchers report that they,ve discovered a ... a finding that might provide insight into how the germ ... About 200 million people around the world are thought ... chronically infected people in the United States. Many don,t know ...
... , NEW YORK, May 23, 2011More than eight of ... believe states should be allowed to implement key provisions ... support, ahead of the timeline outlined in the law. ... more low-income families and creating insurance exchanges with premium ...
... , MONDAY, May 23 (HealthDay News) -- Undercover research ... to provide emergency care to children with private insurance ... Posing as mothers of a fictional 10-year-old boy ... 85 dental practices twice, four weeks apart, to determine ...
... is a reasonably safe and accurate method for the initial ... April issue of the Journal of the American College ... shave biopsies for not providing accurate T (tumor) stage information, ... to determine the impact of shave biopsies on the initial ...
Cached Medicine News:Health News:Losing Baby Weight Cuts Odds of Pregnancy-Linked Diabetes 2Health News:'Top 5' list helps primary care doctors make wiser clinical decisions 2Health News:'Top 5' list helps primary care doctors make wiser clinical decisions 3Health News:Researchers Find Cousin of Hepatitis C Virus in Dogs 2Health News:States should be allowed to implement key health reform law provisions early, experts say 2Health News:States should be allowed to implement key health reform law provisions early, experts say 3Health News:Some Dentists Reluctant to Treat Kids on Medicaid: Study 2Health News:Some Dentists Reluctant to Treat Kids on Medicaid: Study 3Health News:Shave biopsy is a safe and acceptable method for initial evaluation of melanoma 2
1000 L, Bulk Recommended for 500 and 1000 L pipettes....
Inquire...
... way to order tips. Each box contains 1000 ... which contains 200 tips (4 bags of 50 ... of 200 tips per pack. Bulk Packs are ... be opened for quick access to Gilsons Diamond ...
... Finntips have been designed to optimize the ... of our tip products is widely recognized ... range has been extended over the years ... standard and special tips including filter tips, ...
Medicine Products: